NAUT — Nautilus Biotechnology Share News
0.000.00%
Last trade - 00:00- $412.31m
- $328.28m
Brief: Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
Brief: Nautilus Biotechnology Q2 EPS USD -0.11
Nautilus Biotechnology Inc expected to post a loss of 13 cents a share - Earnings Preview
Nautilus Biotechnology Q1 net loss narrows as expenses fall
Brief: Nautilus Biotechnology Q1 EPS USD -0.12
Brief: Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust As Vice President Of Sales
Nautilus Q4 operating expenses fall 23%, net loss narrows
Brief: Nautilus Biotechnology Inc - Commercial Launch Of Voyager Platform Expected In Late 2026
Nautilus Biotechnology Q3 net loss narrows on lower operating expenses
Brief: Nautilus Biotechnology Inc - Quarterly Net Loss Per Share $0.11 - Filing
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology Q2 net loss narrows as expenses drop
Brief: Nautilus Biotechnology Announces Agreement With The Allen Institute, Further Validating Its Approach To Single-Molecule Proteomics
Nautilus Biotechnology Inc expected to post a loss of 15 cents a share - Earnings Preview
Nautilus Biotechnology Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Nautilus Biotechnology Q1 EPS USD -0.13
Brief: Nautilus Biotechnology Posts Qtrly Loss Per Share $0.13